Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

What do we know about the epidermis' optical properties and their influence on optical device functionality?

Biophotonics discovery·2026

Same author

Lyocell-modal thread microfluidic platform integrated with a microneedle sensor for lactate detection in saliva.

Lab on a chip·2026

Same author

High Sensitivity Cardiac Troponin I Detection via MP-Locked Aptamer and Multimeric DNAzyme-Coupled Hyperbranched Hybridization Chain Reaction.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Smart Catheters for Diagnosis, Monitoring, and Therapy.

Advanced healthcare materials·2025

Same author

Robust Prediction of Cardiorespiratory Signals from a Multimodal Physiological System on the Upper Arm.

Biosensors·2025

Same author

A Novel Wearable Device for Continuous Blood Pressure Monitoring Utilizing Strain Gauge Technology.

Biosensors·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Published on: March 20, 2015

Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopy.

I-Hsien Chou¹, Melodie Benford, Hope T Beier

¹Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843-3120, USA.

|May 21, 2008

Summary

Detecting changes in beta-amyloid peptide (Abeta) structure is key for Alzheimer's disease diagnosis. A new nanofluidic biosensor successfully observed Abeta

More Related Videos

Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes

Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes

Published on: June 9, 2023

Exploring the Application of Surface-enhanced Raman Scattering-based Biosensing of Individual sEVs in Disease Diagnosis and Therapeutics

Exploring the Application of Surface-enhanced Raman Scattering-based Biosensing of Individual sEVs in Disease Diagnosis and Therapeutics

Published on: March 13, 2026

Related Experiment Videos

Last Updated: Jul 5, 2026

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates

Published on: March 20, 2015

Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes

Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes

Published on: June 9, 2023

Exploring the Application of Surface-enhanced Raman Scattering-based Biosensing of Individual sEVs in Disease Diagnosis and Therapeutics

Exploring the Application of Surface-enhanced Raman Scattering-based Biosensing of Individual sEVs in Disease Diagnosis and Therapeutics

Published on: March 13, 2026

Area of Science:

Biomedical Engineering
Neuroscience
Analytical Chemistry

Background:

Alzheimer's disease is linked to the aggregation of beta-amyloid peptide (Abeta).
Understanding Abeta conformational changes is crucial for early diagnosis.
Existing methods struggle to detect subtle structural transitions in complex biological fluids.

Purpose of the Study:

To develop a novel biosensor for detecting Abeta conformational transitions.
To observe Abeta self-assembly dynamics in real-time.
To differentiate Abeta from other proteins in cerebrospinal fluid.

Main Methods:

Development of a nanofluidic biosensor with a controlled surface-enhanced Raman spectroscopy (SERS) active site.
Utilizing SERS for trace detection of Abeta.
Testing the biosensor's ability to distinguish Abeta conformational states and confounder proteins.

Main Results:

The novel biosensor successfully observed Abeta conformational transitions from alpha-helical to beta-sheet structures.
The system demonstrated the ability to monitor Abeta self-assembly.
The biosensor effectively distinguished Abeta from common cerebrospinal fluid proteins.

Conclusions:

The developed nanofluidic SERS biosensor is a promising tool for Alzheimer's disease research.
This technology enables sensitive detection of critical Abeta structural changes.
The biosensor holds potential for improving early diagnosis of Alzheimer's disease.